-
Mashup Score: 0
Perspective from The New England Journal of Medicine — Updated Health Warnings for Alcohol — Informing Consumers and Reducing Harm
Source: New England Journal of MedicineCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
FDA approves darolutamide tablets for metastatic hormone-sensitive prostate cancer
Categories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Perioperative Beta-Blocker Supply and Survival in Women With Epithelial Ovarian Cancer and a History of Cardiovascular Conditions - 2 year(s) ago
PURPOSE Surgery for epithelial ovarian cancer (EOC) may activate stress-inflammatory responses that stimulate tumor growth and increase metastatic growth. Animal and in vitro studies have shown that inhibition of the catecholamine-induced inflammatory response via beta-adrenergic receptor blockade has antitumor potential in EOC. However, observational studies have reported mixed results. We…
Source: Journal of Clinical OncologyCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 6
Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co‐primary or secondary analyses are not yet available. Clinical Trial Updates provide an opportunity to disseminate additional results from studies, published in JCO or elsewhere, for which the primary end point has…
Source: Journal of Clinical OncologyCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Losing Contact — Covid-19, Telemedicine, and the Patient–Provider Relationship | NEJM - 2 year(s) ago
Perspective from The New England Journal of Medicine — Losing Contact — Covid-19, Telemedicine, and the Patient–Provider Relationship
Source: New England Journal of MedicineCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
The KEYNOTE-365 study assessed the efficacy and safety of pembrolizumab combination therapies in metastatic castration-resistant prostate cancer (mCRPC). In cohort A, pembrolizumab plus olaparib showed antitumor activity and manageable safety in patients with molecularly unselected, docetaxel-pretreated mCRPC.
Source: European UrologyCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Incidence of Cardiovascular Events in Patients Treated With Immune Checkpoint Inhibitors - 2 year(s) ago
PURPOSE In rare cases, immune checkpoint inhibitors (ICIs) cause immune-mediated myocarditis. However, true incidence of other major adverse cardiovascular events (MACEs) after ICI treatment remains unknown, mainly because late occurring side effects are rarely reported in prospective clinical trials. The aims of this study were (1) to identify incidence and risk factors of MACE in a real-life…
Source: Journal of Clinical OncologyCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0
A biopsy-free diagnostic pathway in prostate cancer (PC) is limited by the diagnostic accuracy of multiparametric magnetic resonance imaging (mpMRI). …
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 8
Prostate cancer is the most heritable cancer. There is a need to identify possible modifiable factors for men at an increased risk of prostate cancer …
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet
-
Mashup Score: 0Identification and Validation of the Prognostic Impact of Metastatic Prostate Cancer Phenotypes - 2 year(s) ago
Castration-sensitive metastatic prostate cancer is heterogeneous. Our objective is to identify metastatic prostate cancer phenotypes and their prognos…
Source: www.sciencedirect.comCategories: Hem/Oncs, Latest HeadlinesTweet
https://t.co/hPEV36NPbi